Adjuvant chemotherapy improves overall survival in patients with stage IB non-small cell lung cancer

The use of adjuvant chemotherapy in early-stage non-small cell lung cancer (NSCLC) patients improves overall survival (OS) and 5-year OS in patients with tumor sizes ranging from 3 – 7 cm.
Related Posts:EORTC-ETOP study opens on pembrolizumab designed for…Immunotherapy with live bacterium improves response rate in…Chemoradiotherapy after surgery for gastric malignancy showsNew nanopharmaceutical may help overcome resistance to…Drug shows surprising efficacy as therapy for chronic…The post Adjuvant chemotherapy improves overall survival in patients with stage IB non-small cell lung cancer appeared first on My Irritable Bowel Syndrome Story.

Source: My Irritable Bowel Syndrome Story - June 13, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs